UPLOAD Filing
Nuo Therapeutics, Inc.
Date: May 6, 2025 · CIK: 0001091596 · Accession: 0000000000-25-004769
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286912
Letter
Re: Nuo Therapeutics, Inc. Registration Statement on Form S-3 Filed May 1, 2025 File No. 333-286912 Dear David Jorden:
May 6, 2025
David Jorden Chief Executive Officer Nuo Therapeutics, Inc. 8285 El Rio Street, Suite 190 Houston, TX 77054
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jane Park at 202-551-7439 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Industrial
Applications and
Services
cc: David T. Mittelman, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> May 6, 2025 David Jorden Chief Executive Officer Nuo Therapeutics, Inc. 8285 El Rio Street, Suite 190 Houston, TX 77054 Re: Nuo Therapeutics, Inc. Registration Statement on Form S-3 Filed May 1, 2025 File No. 333-286912 Dear David Jorden: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jane Park at 202-551-7439 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: David T. Mittelman, Esq. </TEXT> </DOCUMENT>